Kolexia
Maire Pascal
Pharmacien
Hôpital Lyon Sud
Pierre-Bénite, France
38 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tuberculose Maladies du rein Tuberculose pulmonaire Mauvais usage des médicaments prescrits Défaillance rénale chronique Sepsie Fistule artérioveineuse Infections bactériennes Infections à Pseudomonas

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Population Pharmacokinetics of Vancomycin in Patients Receiving Hemodialysis in a Malian and a French Center and Simulation of the Optimal Loading Dose.
Therapeutic drug monitoring   03 février 2023
Antibiotic therapy for infectious hemodialysed patients in Bamako: Pharmacokinetic analyses and first improvement suggestions.
Annales pharmaceutiques francaises   01 juin 2022
To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
Therapeutic drug monitoring   17 novembre 2021
Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
The Journal of antimicrobial chemotherapy   13 juin 2018
Evaluation of haemodialysis as a protective technique for preventing high daily dose amikacin nephrotoxicity: an experimental study in an ovine model.
International journal of antimicrobial agents   06 juillet 2017
Implications of using the MDRD or CKD-EPI equation instead of the Cockcroft-Gault equation for estimating renal function and drug dosage adjustment in elderly patients.
Fundamental & clinical pharmacology   05 octobre 2016
The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy.
Current pharmaceutical design   05 mai 2016
Mathematical modeling and systems pharmacology of tuberculosis: Isoniazid as a case study.
Journal of theoretical biology   05 avril 2016
Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study.
Fundamental & clinical pharmacology   26 octobre 2015
Population modeling and simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of isoniazid in lungs.
Antimicrobial agents and chemotherapy   15 juin 2015